Importantly, inhibition of PDH by the pharmacological inhibitor CPI-613 not only reduced the population of Lal–/– CD11c+ MDSCs and their PD-L1 expression (Figure 4H) but also reversed their capabilities of T cell suppression and tumor growth stimulation (Figure 4, I and J). The gene discussed is PDP1; the disease is neoplasm.